1 0 0 0 -Benzyl-4,4 0 0 00 0 0 -bis(4-chlorophenyl)-3-(2,6-dichlorophenyl)-1 0 0 00 0 0 -methyl-4,5dihydroisoxazole-5-spiro-3 0 0 0 -piperidine-5 0 0 0 -spiro-3 0 0 00 0 0 -pyrrolidine-2 0 0 00 0 0 -spiro-3 0 0 00 0 00 0 0indoline-2 0 0 00 0 00 0 0 ,4 0 0 0 -dione Key indicators: single-crystal X-ray study; T = 113 K; mean (C-C) = 0.005 Å;
The asymmetric unit of the title compound, C 43 H 34 Cl 4 N 4 O 3 , contains two crystallographically independent molecules. In both molecules, the pyrrolidine ring adopts a twist conformation, the oxindole units are slightly distorted from planarity and the isoxazoline ring adopts an envelope conformation. The crystal structure is stabilized by N-HÁ Á ÁO hydrogenbonding interactions giving one-dimensional chain structures.
Related literature
For the biological activity of spiro compounds, see: James et al. (1991) ; Kobayashi et al. (1991) . For the use of 1,3-dipolar cycloaddition reactions in the construction of spiro compounds, see: Caramella & Grunanger (1984 Table 1 Hydrogen-bond geometry (Å , ).
D-HÁ Á ÁA
D -H HÁ Á ÁA D Á Á ÁA D -HÁ Á ÁA N4-H4Á Á ÁO6 i 0.87 (5) 1.94 (5) 2.804 (4) 176 (4) N8-H8Á Á ÁO3 ii 0.68 (5) 2.14 (5) 2.808 (4) 173 (5) N-H···O hydrogen-bonding interactions (Table 1) giving one-dimensional chain structures. The absolute configuration for (I) was not confirmed in this analysis, the Flack parameter (Flack, 1983) [0.187 (12) : 4589 Friedel pairs] for the configuration reported [C1,C44(S, C3,C46R, C6,C49R, C27,C70(S, C29,C72(S)] being inconclusive.
Experimental
A mixture of 1''-Benzyl-5''-(4-chlorobenzylidene)-4'-(4-chlorophenyl)-1'-methyl-2,3-\ dihydro-1H-indole-3-spiro-2'pyrrolidine-3'-spiro-3''-piperidine-2,\ 3''-dione (1 mmol) and 2,6-dichloro-benzonitrile oxide (1.5 mmol) were dissolved in dry benzene (30 ml) and heated under reflux for 24 h. After completion of the reaction as indicated by TLC, the solvent was evaporated under vacuum. The residue was purified by column chromatography employing a petroleum ether/ethyl acetate mixture (5:1 v/v) as eluent, to obtain the title compound (I). A 20 mg sample of (I) was dissolved in 15 ml of a petroleum ether-ethyl acetate mixture which was allowed to evaporate at room temperature over 15 days, giving colorless single crystals suitable for X-ray analysis.
Refinement
All H atoms attached to C were fixed geometrically and treated as riding with C-H = 0.95 Å (aromatic), 0.98 Å (methyl), 0.99 Å (methylene), 1.00 Å (methine) with U iso (H) = 1.2U eq (C) or 1.5U eq (methane C). The H atoms on N4 and N8 were located in a difference Fourier and both positional and isotropic displacement parameters were refined. The absolute configuration for both molecules [C1, C44(S, C3, C46R, C6, C49R, C27, C70(S, C29, C72(S)], as indicated by the Flack parameter [0.187 (12): 4589 Friedel pairs], was not conclusive but was adopted as a better alternative to that for the enantiomer. supplementary materials sup-2 1'-Benzyl-4,4''-bis(4-chlorophenyl)-3-(2,6-dichlorophenyl)-1''-methyl-4,5-dihydroisoxazole-5-spiro-3'-piperidine-5'-spiro-3''-pyrrolidine-2''-spiro-3'''-indoline-2''',4'-dione (4) Cl3 0.0757 (9) 0.0570 (8) 0.0770 (9) −0.0234 (7) −0.0587 (8) 0.0254 (7) Cl4 0.0384 (6) 0.0441 (7) 0.0687 (8) −0.0124 (5) −0.0201 (5) 0.0121 (6) Cl5 0.0363 (5) 0.0324 (5) 0.0383 (5) −0.0095 (4) −0.0095 (4) 0.0021 (4) Cl6 0.0390 (5) 0.0309 (5) 0.0375 (5) −0.0006 (4) −0.0046 (4) 0.0103 (4) Cl7 0.0486 (6) 0.0523 (7) 0.0513 (6) 0.0114 (5) 0.0312 (5) 0.0121 (5) Cl8 0.0383 (6) 0.0486 (7) 0.0673 (7) 0.0163 (5) 0.0163 (5) 0.0060 (6) 
